SMALL CELL LUNG CANCER EXTENSIVE STAGE
Clinical trials for SMALL CELL LUNG CANCER EXTENSIVE STAGE explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER EXTENSIVE STAGE trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER EXTENSIVE STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to shrink tough lung cancer
Disease control Recruiting nowThis study tests two experimental drugs, gocatamig and I-DXd, for people with extensive-stage small cell lung cancer (ES-SCLC) that has spread. The drugs work by helping the immune system attack cancer cells or delivering treatment directly to them. The study will check safety an…
Matched conditions: SMALL CELL LUNG CANCER EXTENSIVE STAGE
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 06:12 UTC
-
New Gene-Immuno combo aims to keep lung cancer at bay
Disease control Recruiting nowThis study tests a new gene therapy (quaratusugene ozeplasmid) combined with an immunotherapy drug (atezolizumab) as maintenance treatment for people with extensive-stage small cell lung cancer who have already responded to initial chemo-immunotherapy. The goal is to see if this …
Matched conditions: SMALL CELL LUNG CANCER EXTENSIVE STAGE
Phase: PHASE1, PHASE2 • Sponsor: Genprex, Inc. • Aim: Disease control
Last updated May 26, 2026 06:04 UTC
-
Cancer radiotherapy gets personal: new trial adapts treatment in real time
Disease control Recruiting nowThis early-stage trial is testing whether personalizing standard radiotherapy based on how a patient's tumor responds can be safe and effective. It includes two groups: one for extensive-stage small cell lung cancer patients receiving chemoimmunotherapy, and another for people wi…
Matched conditions: SMALL CELL LUNG CANCER EXTENSIVE STAGE
Phase: PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated May 20, 2026 11:58 UTC
-
Triple therapy attack on tough lung cancer shows promise in new trial
Disease control Recruiting nowThis study is for people with extensive-stage small cell lung cancer, a fast-growing type of lung cancer that has spread. The trial tests whether adding a low dose of radiation to a combination of immunotherapy (adebrelimab) and chemotherapy can help patients live longer. About 2…
Matched conditions: SMALL CELL LUNG CANCER EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated May 20, 2026 11:56 UTC